News & Updates

Show Multimedia Only

Does LMWH improve live birth rate in women with inherited thrombophilia and miscarriage history?

06 Feb 2023 by

The use of low-molecular-weight heparin (LMWH) during pregnancy did not increase the likelihood of live birth compared with standard surveillance in women with inherited thrombophilia who have experienced multiple miscarriages, according to a multinational study presented at ASH 2022.

Does LMWH improve live birth rate in women with inherited thrombophilia and miscarriage history?

06 Feb 2023

Buprenorphine use during pregnancy linked to better neonatal outcomes

06 Feb 2023 by

The use of buprenorphine during pregnancy appears to be associated with a lower risk of adverse neonatal outcomes compared with methadone use. However, adverse maternal outcomes are similar for both therapies, according to a recent study.

Buprenorphine use during pregnancy linked to better neonatal outcomes

06 Feb 2023

Letrozole outperforms clomiphene citrate for ovulation induction

06 Feb 2023

The use of letrozole for inducing ovulation in women with infertility and polycystic ovarian syndrome (PCOS) appears to yield improvements in ovulation, pregnancy, and live-birth rates as compared with clomiphene citrate, according to a study.

Letrozole outperforms clomiphene citrate for ovulation induction

06 Feb 2023

Original New Drug Application Approvals by US FDA (16-31 January 2023)

31 Jan 2023

New drug applications approved by US FDA as of 16-31 January 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 January 2023)

31 Jan 2023

Ospemifene improves vaginal microbiome of women with vulvovaginal atrophy

29 Jan 2023

Women with vulvovaginal atrophy exhibit a less favourable vaginal microbiome than healthy postmenopausal women, but ospemifene may restore vaginal health by reducing potentially harmful bacteria, as shown in a study.

Ospemifene improves vaginal microbiome of women with vulvovaginal atrophy

29 Jan 2023

Are children conceived with assisted technologies at risk for cardiometabolic events?

27 Jan 2023

Children conceived by their parents through non-in vitro fertilization fertility treatment show no metabolic difference from those conceived spontaneously, according to a study.

Are children conceived with assisted technologies at risk for cardiometabolic events?

27 Jan 2023

Diminished ovarian reserve linked to pre-eclampsia, placental vascular lesions

26 Jan 2023

Among pregnant women who conceived via in vitro fertilization (IVF), diminished ovarian reserve appears to contribute to a higher incidence of pre-eclampsia and multiple placental vascular lesions of foetal origin, as reported in a study.

Diminished ovarian reserve linked to pre-eclampsia, placental vascular lesions

26 Jan 2023

NAFLD, regardless of obesity status, ups risk of adverse pregnancy outcomes

26 Jan 2023

Women with nonalcoholic fatty liver disease (NAFLD), despite having a normal weight, remains at greater risk of adverse pregnancy outcomes, reveals a study.

NAFLD, regardless of obesity status, ups risk of adverse pregnancy outcomes

26 Jan 2023

PCOS does not make COVID-19 worse for women

25 Jan 2023

In women who have contracted COVID-19, the presence of polycystic ovary syndrome (PCOS) does not appear to drive the risk of increased disease severity, according to a study.

PCOS does not make COVID-19 worse for women

25 Jan 2023

Trastuzumab deruxtecan confers hope as second-line therapy for HER2+ mBC

20 Jan 2023 by

Updated results of the DESTINY-Breast03 trial, presented at SABCS 2022, showed that in patients with HER2+ metastatic breast cancer, second-line treatment with trastuzumab deruxtecan conferred better survival benefits than treatment with trastuzumab emtansine.

Trastuzumab deruxtecan confers hope as second-line therapy for HER2+ mBC

20 Jan 2023

News & Updates

Showing Obstetrics & Gynaecology articles

Showing

Specialty:

Does LMWH improve live birth rate in women with inherited thrombophilia and miscarriage history?

Does LMWH improve live birth rate in women with inherited thrombophilia and miscarriage history?

Buprenorphine use during pregnancy linked to better neonatal outcomes

Buprenorphine use during pregnancy linked to better neonatal outcomes

Letrozole outperforms clomiphene citrate for ovulation induction

Letrozole outperforms clomiphene citrate for ovulation induction

Original New Drug Application Approvals by US FDA (16-31 January 2023)

Original New Drug Application Approvals by US FDA (16-31 January 2023)

Ospemifene improves vaginal microbiome of women with vulvovaginal atrophy

Ospemifene improves vaginal microbiome of women with vulvovaginal atrophy

Are children conceived with assisted technologies at risk for cardiometabolic events?

Are children conceived with assisted technologies at risk for cardiometabolic events?

Diminished ovarian reserve linked to pre-eclampsia, placental vascular lesions

Diminished ovarian reserve linked to pre-eclampsia, placental vascular lesions

NAFLD, regardless of obesity status, ups risk of adverse pregnancy outcomes

NAFLD, regardless of obesity status, ups risk of adverse pregnancy outcomes

PCOS does not make COVID-19 worse for women

PCOS does not make COVID-19 worse for women

Trastuzumab deruxtecan confers hope as second-line therapy for HER2+ mBC

Trastuzumab deruxtecan confers hope as second-line therapy for HER2+ mBC